Skip to main content
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. logo

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. — Investor Relations & Filings

Ticker · 000661 ISIN · CNE0000007J8 LEI · 300300X04OTKZG18WD66 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,287 across all filing types
Latest filing 2025-04-20 Notice of Dividend Amou…
Country CN China
Listing Shenzhen Stock Exchange 000661

About CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.

https://ccht.jl.cn

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. is a diversified enterprise primarily focused on the research, development, production, and distribution of biopharmaceuticals and healthcare products. The company operates through several key subsidiaries, most notably GeneScience Pharmaceuticals, which specializes in recombinant human growth hormones and pediatric endocrinology treatments. Its product portfolio includes biological drugs, vaccines, and traditional Chinese medicines, targeting therapeutic areas such as growth disorders, infectious diseases, and oncology. The group emphasizes technological innovation and maintains a significant presence in the domestic market while expanding its international footprint. In addition to its core life sciences business, the company maintains interests in real estate development and infrastructure management.

Recent filings

Filing Released Lang Actions
2024年度利润分配方案公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the 2024 profit distribution plan of Changchun High-tech Industry (Group) Co., Ltd. It details the cash dividend distribution, share repurchase amounts, net profit figures, and compliance with regulatory guidelines. The document does not contain full financial statements or comprehensive financial performance data but focuses on the dividend distribution plan and related shareholder return information. The document length is 2240 characters, which is relatively short and primarily serves as a formal announcement of the dividend plan rather than a full report. Therefore, it fits best under the category of Notice of Dividend Amount (DIV).
2025-04-20 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding changes in accounting policies by the company 长春高新技术产业（集团）股份有限公司. It references new accounting standards and interpretations issued by the Ministry of Finance of China and explains the nature, reasons, and impact of the accounting policy changes. The document explicitly states that the changes do not require board or shareholder approval and will not materially affect financial results. It is a regulatory announcement about accounting policy changes rather than a full financial report, audit report, or management discussion. It does not contain financial statements or detailed financial analysis. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-04-20 Chinese
2024年年度财务报告
Annual Report Classification · 100% confidence The document is titled as the 2024 Annual Financial Report of 长春高新技术产业（集团）股份有限公司, dated April 2025. It contains detailed audited financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and notes. The presence of an audit report with an unqualified opinion from a registered accounting firm is included. The document covers the full fiscal year 2024 and provides comprehensive financial data and management responsibilities. This matches the definition of an Annual Report (10-K) which is a full yearly report covering company activity and full financial performance. The document is lengthy (15,000 characters) and contains substantive financial data, not just an announcement or certification. Therefore, the correct classification is Annual Report (10-K). FY 2024
2025-04-20 Chinese
2024年度独立董事述职报告（张伟明）
Board/Management Information Classification · 95% confidence The document is titled '2024年度独立董事述职报告' which translates to '2024 Annual Independent Director's Work Report'. It details the independent director's duties, attendance at board and committee meetings, communication with auditors, and overall governance activities during the year 2024. The content focuses on the director's report on their role and activities rather than financial statements or audit results. It is a specialized governance-related report by an independent director, not a full annual report, audit report, or other financial filing. This fits best under Board/Management Information (MANG) as it relates to management and board-level disclosures about director activities and governance. The document length is about 4831 characters, sufficient for a detailed report but not a full financial report. There is no indication of financial statements or earnings data. Therefore, the classification is MANG with high confidence.
2025-04-20 Chinese
2024年度独立董事述职报告（张春颖）
Management Reports Classification · 95% confidence The document is titled as the "2024年度独立董事述职报告" which translates to "2024 Annual Independent Director's Work Report." It details the independent director's background, attendance at meetings, participation in committees, communication with shareholders, oversight of financial reports, internal controls, and governance activities during the year 2024. The content is a detailed report on the independent director's duties and activities over the year, including evaluations of financial and governance matters. It is not an announcement or a brief summary but a substantive report on management and governance activities. This fits best under the category of Management Reports (MDA), which covers management's detailed explanation of financial results, business trends, and outlook, including governance and oversight activities by directors. The document is not an Annual Report (10-K), Audit Report (AR), or Governance Information (CGR) as it focuses specifically on the independent director's annual work report. The length and detail confirm it is a full report, not a publication announcement or regulatory filing. Therefore, the classification is MDA with high confidence.
2025-04-20 Chinese
关联交易管理制度（2025年4月修订）
Governance Information Classification · 95% confidence The document is titled as a "关联交易管理制度" which translates to "Related Party Transaction Management System". It is a detailed internal policy document outlining the principles, definitions, decision-making procedures, disclosure requirements, and voting recusal rules related to related party transactions within the company. It references relevant laws and stock exchange rules, and is approved by the company's board of directors. The document is not a financial report, earnings release, or announcement of voting results. It is a governance-related document detailing internal rules and procedures for managing related party transactions. Therefore, it fits best under Governance Information (CGR). The document length (6583 characters) and content confirm it is a full policy document, not a brief announcement or certification.
2025-04-20 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.